11:49 AM EST - Bioniche Life Sciences Inc. : announced that it has signed an agreement with Thorn BioScience LLC, a subsidiary of CreoSalus, Inc. The agreement provides exclusive rights to Bioniche to market and distribute CreoSalus' SucroMate(TM))Equine product in the U.S., with a first right of negotiation to expand the territory. Bioniche Life Sciences Inc.
shares T.BNC are trading even at $1.38.
